Overview A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation Status: Terminated Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Phase 2 study, conducted in patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, or mantle cell lymphoma undergoing high-dose chemotherapy and autologous stem cell transplantation. Phase: Phase 2 Details Lead Sponsor: AbbottCollaborators: Dana-Farber Cancer InstituteM.D. Anderson Cancer CenterNorwood Immunology LimitedTreatments: Leuprolide